ATCT-25 LONG-TERM REMISSION OVER 5 YEARS FOR PATIENT WITH RECURRENT GLIOBLASTOMA TREATED WITH CEDIRANIB/LOMUSTINE

Yazar: Hu, Jethro, Richardson, Jaime, Wilson, Joanna, Phuphanich, Surasak
Yayımlandı Neuro Oncol (2015)

IT-26 IDENTIFICATION OF PSEUDO-PROGRESSION IN NEW DIAGNOSED GLIOBLASTOMA (GBM) IN A RANDOMIZED PHASE 2 OF ICT-107: MRI AND PATHOLOGY CORRELATION

Yazar: Phuphanich, Surasak, Yu, John, Bannykh, Serguei, Zhu, Jay-Jiguang
Baskı/Yayın Bilgisi 2014

RM-02 LONG-TERM SURVIVAL IN GLIOBLASTOMA PATIENTS FOLLOWING STROKE: A NON-CONSECUTIVE CASE SERIES

Yazar: Hu, Jethro, Phuphanich, Surasak, Fan, Xuemo, Rudnick, Jeremy, Prasad, Ravi
Yayımlandı Neuro Oncol (2014)

Movement-Based Therapies in Rehabilitation

Yazar: Phuphanich, Melissa E., Droessler, Jonathan, Altman, Lisa, Eapen, Blessen C.
Yayımlandı Phys Med Rehabil Clin N Am (2020)

Long-term Remission Over Six Years for a Patient with Recurrent Glioblastoma Treated with Cediranib/Lomustine

Yazar: Drazin, Doniel, Al-Khouja, Lutfi, Patel, Ashish, Hu, Jethro, Phuphanich, Surasak
Yayımlandı Cureus (2016)

Post-irradiation lumbosacral radiculopathy associated with multiple cavernous malformations of the cauda equina: Case report and review of the literature

Yazar: Drazin, Doniel, Kappel, Ari, Withrow, Stefan, Perry, Tiffany, Chu, Ray, Phuphanich, Surasak
Yayımlandı Surg Neurol Int (2017)

Risk factors for differential outcome following directly observed treatment (DOT) of slum and non-slum tuberculosis patients: a retrospective cohort study

Yazar: Snyder, Robert E., Marlow, Mariel A., Phuphanich, Melissa E., Riley, Lee W., Maciel, Ethel Leonor Noia
Yayımlandı BMC Infect Dis (2016)

Disinfectants In Interventional Practices

Yazar: Aranke, Mayank, Moheimani, Roya, Phuphanich, Melissa, Kaye, Alan D., Ngo, Anh L., Viswanath, Omar, Herman, Jared
Yayımlandı Curr Pain Headache Rep (2021)

IMCT-12 A PHASE 1 TRIAL OF VACCINATION WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE DERIVED FROM AN ALLOGENEIC GLIOBLASTOMA STEM-LIKE CELL LINE FOR PATIENTS WITH NEWLY DIAGNO...

Yazar: Hu, Jethro, Phuphanich, Surasak, Rudnick, Jeremy, Mazer, Mia, Wang, HongQiang, Wheeler, Christopher, Black, Keith, Yu, John
Yayımlandı Neuro Oncol (2015)

ATCT-07 PHASE 2 STUDY OF MEDI-575, AN ANTI-PLATELET-DERIVED GROWTH FACTOR-α ANTIBODY, IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Yazar: Phuphanich, Surasak, Raizer, Jeffrey, Chamberlain, Marc, Canelos, Paola, Narwal, Rajesh, Hong, Shengyan, Miday, Robert, Nade, Minal, Laubscher, Kevin
Yayımlandı Neuro Oncol (2015)

PATH-55. MUTATIONS OF H3.3 AND H3.1 IN A LARGE COHORT OF GLIOMAS

Yazar: Sumrall, Ashley, Mittal, Sandeep, Phuphanich, Surasak, Heimberger, Amy, Eschbacher, Jenny, Korn, Michael, Gatalica, Zoran, Pandey, Manjari, Xiu, Joanne
Yayımlandı Neuro Oncol (2019)

Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma

Yazar: Phuphanich, Surasak, Carson, Kathryn A., Grossman, Stuart A., Lesser, Glenn, Olson, Jeffrey, Mikkelsen, Tom, Desideri, Serena, Fisher, Joy D.
Baskı/Yayın Bilgisi 2008

OS2.5 Long term remission/survival over 8 years in patients with newly diagnosed glioblastoma (GBM) treated with ICT-107 dendritic cell-based immunotherapy (phase I)

Yazar: Phuphanich, S., Wheeler, C., Rudnick, J., Hu, J., Mazer, M., Nuño, M., Sanchez, C., Chu, R., Black, K., Yu, J.
Yayımlandı Neuro Oncol (2016)

Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma,

Yazar: Brem, Steven, Grossman, Stuart A., Carson, Kathryn A., New, Pamela, Phuphanich, Surasak, Alavi, Jane B., Mikkelsen, Tom, Fisher, Joy D.
Baskı/Yayın Bilgisi 2005

Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: A dose escalation and pharmacologic study

Yazar: Phuphanich, Surasak, Baker, Sharyn D., Grossman, Stuart A., Carson, Kathryn A., Gilbert, Mark R., Fisher, Joy D., Carducci, Michael A.
Baskı/Yayın Bilgisi 2005

DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas

Yazar: Bellail, Anita C, Tse, Margaret C L, Song, Jin H, Phuphanich, Surasak, Olson, Jeffrey J, Sun, Shi Yong, Hao, Chunhai
Baskı/Yayın Bilgisi 2010

Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma

Yazar: Nabors, L. B., Supko, J. G., Rosenfeld, M., Chamberlain, M., Phuphanich, S., Batchelor, T., Desideri, S., Ye, X., Wright, J., Gujar, S., Grossman, S. A.
Baskı/Yayın Bilgisi 2011

Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas

Yazar: Grossman, Stuart A., Carson, Kathryn A., Phuphanich, Surasak, Batchelor, Tracy, Peereboom, David, Nabors, L. Burt, Lesser, Glenn, Hausheer, Fredrick, Supko, Jeffrey G.
Baskı/Yayın Bilgisi 2008

A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients

Yazar: Phuphanich, Melissa, Rattanamahattana, Maneerat, Avihingsanon, Anchalee, Chetchotisakd, Ploenchan, Putcharoen, Opass, Gandhi, Monica, Sohn, Annette H, Imrie, John, Phanuphak, Praphan, Kerr, Stephen J
Yayımlandı J Virus Erad (2016)

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

Yazar: Rudek, Michelle A., New, Pamela, Mikkelsen, Tom, Phuphanich, Surasak, Alavi, Jane B., Nabors, Louis B., Piantadosi, Steven, Fisher, Joy D., Grossman, Stuart A.
Baskı/Yayın Bilgisi 2011